Shanghai
Merck will begin construction in August of 2014 on a 430,000-sf pharmaceutical production plant in Shanghai. The $107 million facility will manufacture drugs for diabetes as well as thyroid and heart conditions. Completion is expected in 2016 and commercial production will begin in 2017.
